本則回應

• Pei-Chi Lo標記此篇為：💬 含有個人意見

  理由

  ■李教授臉書依據的Lancet論文【不是】大規模研究，論文內即有說明僅納少數患者(共23人)是此研究的限制之一。
  　
  ■所提的研究結果大抵正確，但相關防疫措施建議屬李教授個人意見，例如：
  　
  ①研究中僅說「初始有症狀即有高病毒量，表示在症狀相對輕微時即可輕易傳染」；但並未認為無症狀時即可
  閱讀更多

  不同意見

  針對無症狀可否傳染，WHO、美國CDC有不同看法：
  
  2020年3月5日WHO記者會逐字稿，00:23:24起說明無症狀傳染可能發生，但應非驅動本次疫情的主要動力：
  https://www.who.int/docs/default-source/⋯ce-final-05mar2020.pdf?sfvrsn=3855ddcd_0
  
  美國CDC官網-「Q: When is someone infectious?」段認為雖有無症狀傳染的報導，但尚不知其在疫情傳播扮演的角色：
  https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html
  
  --
  李教授引用的Lancet論文原文：
  https://www.thelancet.com/journals/lanin⋯rticle/PIIS1473-3099(20)30196-1/fulltext

  https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-final-05mar2020.pdf?sfvrsn=3855ddcd_0

  URL is malformed or not supported

  Coronavirus Disease 2019 (COVID-19)

  https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html

  Q: What are the clinical features of COVID-19? A: The clinical spectrum of COVID-19 ranges from mild disease with non-specific signs and symptoms of acute respiratory illness, to severe pneumonia with

  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

  https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30196-1/fulltext

  Kelvin Kai-Wang To, MD †Kelvin Kai-Wang ToFootnotes† Contributed equallyAffiliationsState Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, L